Jacqueline E. Shea - 09 Jun 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Operating Officer
Signature
/s/ Jacqueline E. Shea
Issuer symbol
INO
Transactions as of
09 Jun 2021
Net transactions value
-$385,735
Form type
4
Filing time
11 Jun 2021, 16:26:51 UTC
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Sale $385,735 -38,535 -64% $10.01* 21,592 09 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 These transactions were executed in multiple trades at prices ranging from $10.00 to $10.06, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.